… ProQR to Participate in Upcoming Investor Conferences LEIDEN, … & CAMBRIDGE, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a … 30 days following the presentation date. About ProQRProQR Therapeutics is dedicated to changing lives …
… ProQR Announces Proposed Public Offering of Ordinary Shares … LEIDEN, the Netherlands, Nov. 13, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a biopharmaceutical … public offering. All of the shares are being offered by ProQR. In addition, in the public offering, ProQR expects to …
… ProQR Appoints Theresa Heggie as Chief Commercial Officer … (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through the … brings a wealth of commercial and leadership skills to ProQR, having built commercial organizations and successfully …
… ProQR to Present at Upcoming SVB Leerink Conference LEIDEN, … will be accessible from the “Investors & Media” section of ProQR’s website ( www.proqr.com ) under “ Events ”. Archived webcasts will be …
… ProQR Announces Presentations at the OTS Annual Meeting … on QR-110 clinical data in LCA10 David Rodman, MD, EVP of R&D of ProQR, will give a presentation on the recent clinical data …
… ProQR Announces First Quarter 2024 Operating and Financial … & CAMBRIDGE, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company … expression of the protein. A strong correlation (R 2 = 0.51) is reported between editing levels of NTCP and …
… ProQR Announces Year End 2023 Operating and Financial Results … (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through … said Daniel A. de Boer, Chief Executive Officer of ProQR. “We announced our initial pipeline programs, AX-0810 …